跳至主要内容
临床试验/IRCT20211024052857N1
IRCT20211024052857N1招募中3 期

The effects of probiotics administration on acute side effects of chemotherapy regimens in gastroesophageal cancer patients

Karaj University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with gastroesophageal cancer stage 3,4 who had chemotherapy(dcf,folfox)-induced side effects and were older than 18 with first-grade tumor.

排除标准

  • Patients with severe systematic disease (such as heart, kidney, and liver) or previously had chemotherapy or were given antibiotics and probiotics.

研究者

发起方
Karaj University of Medical Sciences

相似试验